Table 1.
Associations between MCU expression and clinicopathological characteristics in OSCC patients
| Clinical parameters | Total (n = 79) | MCU |
χ2 | P-value | |
|---|---|---|---|---|---|
| Positive (n = 57) |
Negative (n = 22) |
||||
| Age (years) | |||||
| <60 | 41 | 31 (75.6%) | 10 (24.4%) | 0.507 | 0.476 |
| ≥60 | 38 | 26 (68.4%) | 12 (31.6%) | ||
| Sex | |||||
| Male | 40 | 27 (67.5%) | 13 (32.5%) | 0.873 | 0.350 |
| Female | 39 | 30 (76.9%) | 9 (23.1%) | ||
| Depth of invasion | |||||
| T1/T2 | 24 | 11 (45.8%) | 13 (54.2%) | 11.884 | 0.001 |
| T3/T4 | 55 | 46 (83.6%) | 9 (16.4%) | ||
| Lymph metastasis | |||||
| N0 | 13 | 4 (30.8%) | 9 (69.2%) | 13.262 | <0.0001 |
| N1/N2/N3 | 66 | 53 (80.3%) | 13 (19.7%) | ||
| TNM stage | |||||
| I–II | 22 | 12 (54.5%) | 10 (45.5%) | 4.704 | 0.030 |
| III–IV | 57 | 45 (78.9%) | 12 (21.1%) | ||
| Distant metastasis | |||||
| Absent | 27 | 14 (51.9%) | 13 (48.1%) | 8.413 | 0.004 |
| Present | 52 | 43 (82.7%) | 9 (17.3%) | ||
| Survival | |||||
| Dead | 32 | 15 (46.9%) | 17 (53.1%) | 17.103 | <0.0001 |
| Alive | 47 | 42 (89.4%) | 5 (10.6%) | ||
TNM, tumor, nodule, metastasis.